Healthtech Startups

LORAI Health develops next-generation transdermal drug delivery technologies for medicines such as hormones, pain therapies, and neurological treatments, with a focus on reliable delivery, patient comfort, and manufacturing resilience. Founded in Australia, it originated in menopausal hormone therapy and works with research, manufacturing, healthcare, and investment partners internationally.

1 investor

Lorals manufactures intimate health products focused on sexual health accessibility and safe practices. The company partners with public health departments, universities, LGBTQ+ centers, and nonprofits to make its products available to underserved communities nationwide.

1 investor

Loresa develops minimally invasive surgical devices for resource-limited settings, with a focus on eliminating the need for insufflation in abdominal surgery. The company serves lower-middle-income countries where access to safe surgery is limited by cost and infrastructure constraints.

1 investor

Lotus Addiction offers addiction rehabilitation and mental health recovery programs, including inpatient care and personalized therapy using Cognitive Behavioral Therapy and Dialectical Behavioral Therapy delivered through video materials and one-on-one counseling. The programs are based in Thailand and aimed at individuals seeking to overcome addiction and rebuild mental, emotional, and physical balance.

1 investor

Lovegood Fats produces high-protein, low-sugar nutrition bars made in Canada, targeting fitness enthusiasts and health-conscious consumers. The bars are formulated to support keto and GLP-1 friendly lifestyles while delivering functional nutrition benefits.

1 investor

Lovevery sells developmental toy kits for infants and toddlers designed to support learning through play, available in age-specific Mini Kit options for gifting or trial purchases.

1 investor

Love Wellness produces Bye Bye Bloat, a digestive supplement containing enzymes and botanicals designed to alleviate bloating and water weight. The product targets consumers seeking relief from hormonal, food-related, and PMS-related bloating.

1 investor

LovShield provides real-time fraud detection and scam prevention specifically designed for seniors and their families. The service uses intelligent technology to identify and block fraudulent calls before they result in financial loss.

1 investor

Loyal provides a Care Activation Platform that enables health systems to deliver personalized patient engagement across the full care journey, from provider search and scheduling to outreach and follow-up, with integrated EHR connectivity and provider data management.

1 investor

Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases. Its lead compound, THRV-1268, is in a Phase 2/3 clinical study for Long QT Syndrome Type 2.

1 investor

LTL Pharma acquires and develops long-established pharmaceutical drugs (long-life medications) from originator manufacturers, maintaining consistent supply and quality standards for healthcare providers and patients. The company specializes in managing mature pharmaceutical products with extensive clinical track records.

1 investor

LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.

1 investor

LUBU makes smart insoles with built-in sensors that capture movement biomechanics and kinetic data to predict injury and track recovery for athletes, military personnel, and patients. The company uses proprietary hardware and AI-driven analysis, drawing on seventy years of footwear manufacturing expertise, to provide lab-grade movement measurement at scale.

1 investor

Luca develops LucaPlex, a modular SaaS platform combining digital biomarkers, AI algorithms, wearable devices, ePRO, and remote patient management to help life science companies and healthcare institutions build digital medicine products. The platform supports clinical trials, drug development, insurance and employee wellness programs by collecting continuous physiological and behavioral health data.

1 investor

Lucea provides AI-powered triage software that pairs automation with clinical intelligence to support clinicians during pediatric triage calls, offering protocol-aligned context while clinicians retain clinical judgment. It is built for pediatric practices and their care teams, focusing on more efficient and consistent triage workflows.

1 investor

Lucem Health applies clinical artificial intelligence to help healthcare providers detect chronic diseases earlier in patients. The company develops AI-driven platforms for healthcare systems to improve disease detection and patient outcomes.

1 investor

Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.

1 investor

Lucent Health provides health benefits administration for self-insured employers, combining claims management with data-driven, human-focused care management to help health plan participants make cost-saving healthcare decisions. The company operates nationwide in the US.

1 investor

Lucentia develops AI software that analyses standard cardiac CT scans to extract additional information about the coronary arteries. The approach is designed to detect signs of heart disease earlier without requiring contrast agents or further scans, using imaging that clinicians already perform routinely.

1 investor

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.

1 investor

LucidHealth is a physician-led healthcare organization that supports a national network of radiology practices across the United States through corporate services including operations, finance, technology, and strategy. The company focuses on empowering radiologists and advancing clinical outcomes in radiology care.

1 investor

1 investor

LucyRx is a pharmacy benefit manager (PBM) that provides transparent pricing, clinical guidance, and AI-powered pharmacy intelligence to health plan sponsors and their members. The company serves commercial and government health plans through a network of over 60,000 pharmacies, utilizing its proprietary LucyIQ analytics platform and clinical care guides to reduce drug costs and improve prescription outcomes.

1 investor

Spreo is an online whiteboard and collaboration platform for agile teams to run ceremonies such as retrospectives, sprint planning, backlog refinement, and planning poker, along with brainstorming, workshops, and diagramming. It offers a shared canvas with templates and tools for remote and distributed product and engineering teams.

1 investor